Pharma Companies Trying To Please Both Trump And Wall Street Stuck Between A Rock And A Hard Place

This post was originally published on this site

President Donald Trump had promised to lower drug costs, but pharmaceutical companies — after six months of a self-imposed hiatus on price hikes — are mostly drifting back toward the status quo. In other pharmaceutical news, expensive hepatitis C drugs aren’t being covered for Medicaid patients in Puerto Rico.